Current Seminars
27/11/2012 - 18:30 -
Business Solution for Emergency Management in Canadian Hospitals
Code Orange, a hospital emergency response code, is activated to manage an influx of persons requiring urgent medical care, as a result of an external disaster. Since the majority of hospitals regularly operate over capacity, this influx can be as minimal as twelve seriously injured persons. Currently in Ontario, the legislated protocol...
20/11/2012 - 18:30 -
Therapeutic Ultrasound: How can we grow revenue of Exogen(TM)?
Smith & Nephew is a leader in the competitive bone stimulation market. This is made possible through the sale of ExogenTM, the only FDA approved LIPUS device on the market. LIPUS, otherwise known as low intensity pulsed ultrasound, has been clinically proven to heal fresh fractures 38% faster and has a heal rate of 86% for non-united fractures...
13/11/2012 - 18:30 -
Mobile Health Solution for Wafarin Management
Warfarin, an anticoagulant, has been actively prescribed for over 60 years, with approximately 4 million Americans currently taking Warfarin. Despite this, there are continuous safety issues associated with Warfarin treatment as patients spend an average of only 57% to 66% of their treatment time in the narrow therapeutic range. Moreover,...
06/11/2012 - 18:30 -
Life Science Software Patents: Mobile Health Product Litigation
The mobile health (mHealth) industry has experienced rapid growth in the last few years. As a result, the number of mHealth patents has steadily increased over time with over 20,000 health-related mobile applications (apps) on the market. In contrast with other sectors within the software industry, very few mHealth-related patent litigations have...
30/10/2012 - 18:30 -
SPIRIT: Can a software system for tracking infection in a hospital become a “product”?
Inappropriate use of antimicrobials is a growing concern for hospitals worldwide. This has led to an increased prevalence of antimicrobial resistant organisms, a problem further exacerbated by the reduced development of novel antimicrobial therapies. Antimicrobials have been found to be inappropriately used in up to 50% of cases. The growing...